hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Urogesic Blue Reformulated Apr 2012]

RxCUI: 1251290
RxNorm name: hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Urogesic Blue Reformulated Apr 2012]
Display name: UROGESIC BLUE REFORMULATED APR 2012 (Oral Pill)
Full name: hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Urogesic Blue Reformulated Apr 2012]
Term type: SBD
Status: Active
Strength: 0.12-81.6-10.8-40.8 mg
Dose form: Tab
Route: Oral Pill
Updated: 2026-08-08 11:35:14

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 052012
Active start: 052012
Multiple ingredient: YES
Branded: YES

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
hyoscyamine sulfate	0.12 MG / 1 EACH	hyoscyamine	hyoscyamine sulfate
sodium phosphate, monobasic	40.8 MG / 1 EACH	sodium phosphate, monobasic	sodium phosphate, monobasic
methenamine	81.6 MG / 1 EACH	methenamine	methenamine
methylene blue	10.8 MG / 1 EACH	methylene blue	methylene blue

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Oral Tablet	317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
hyoscyamine	153970
sodium phosphate, monobasic	235496
methenamine	6832
methylene blue	6878

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	Urogesic Blue (hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG) Oral Tablet, Reformulated Apr 2012	1	NAMES
RxNorm Name	hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Urogesic Blue Reformulated Apr 2012]	1	NAMES
RxNorm Synonym	Urogesic Blue (hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG) Oral Tablet, Reformulated Apr 2012	1	NAMES
TTY	SBD	1	ATTRIBUTES
SPL_SET_ID	2 linked values d820e42d-ad2b-4e11-907b-a94d698ca285 f650dd78-615c-42d3-9b2d-3a989039d80c	2	CODES
RxCUI	1251290	1	CODES
MMSL_CODE	BD26735	1	CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDC	Product NDC	Name	Labeler	Application
0485-0151-01	0485-0151	UROGESIC BLUE METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, and HYOSCYAMINE SULFATE	EDWARDS PHARMACEUTICALS, INC.
0485-0151-30	0485-0151	UROGESIC BLUE METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, and HYOSCYAMINE SULFATE	EDWARDS PHARMACEUTICALS, INC.

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 5 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
00484015101	rxnav_ndcs	yes
00484015130	rxnav_ndcs	yes
00485015101	rxnav_ndcs	yes
00485015130	rxnav_ndcs	yes
00485005101	rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
UROGESIC BLUE	METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, AND HYOSCYAMINE SULFATE	EDWARDS PHARMACEUTICALS, INC.	f650dd78-615c-42d3-9b2d-3a989039d80c	2026-03-05	Warnings, Adverse reactions	Exact identifier ndc (package): 0485-0151-01 ndc (product): 0485-0151 ndc11 (package): 00485015101 rxcui: 1251290
UROGESIC BLUE	METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, AND HYOSCYAMINE SULFATE	EDWARDS PHARMACEUTICALS, INC.	d820e42d-ad2b-4e11-907b-a94d698ca285	2025-08-13	Warnings, Adverse reactions	Exact identifier ndc (package): 0485-0151-30 ndc (product): 0485-0151 ndc11 (package): 00485015130 rxcui: 1251290

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
f650dd78-615c-42d3-9b2d-3a989039d80c	UROGESIC-BLUE 81.6 MG / 40.8 MG / 10.8 MG / 0.12 MG Oral Tablet, Reformulated Apr 2012 [PSN] · hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Urogesic Blue Reformulated Apr 2012] [SBD] · Urogesic Blue (hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG) Oral Tablet, Reformulated Apr 2012 [SY]	3	6	UROGESIC-BLUE™	20260305
d820e42d-ad2b-4e11-907b-a94d698ca285	UROGESIC-BLUE 81.6 MG / 40.8 MG / 10.8 MG / 0.12 MG Oral Tablet, Reformulated Apr 2012 [PSN] · hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Urogesic Blue Reformulated Apr 2012] [SBD] · Urogesic Blue (hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG) Oral Tablet, Reformulated Apr 2012 [SY]	3	4	UROGESIC-BLUE™	20250813

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
f650dd78-615c-42d3-9b2d-3a989039d80c	UROGESIC-BLUE™	EDWARDS PHARMACEUTICALS, INC.	20260305
d820e42d-ad2b-4e11-907b-a94d698ca285	UROGESIC-BLUE™	EDWARDS PHARMACEUTICALS, INC.	20250813
b6d2b268-e65b-455d-ae8b-87dfc7c59fdb		National Council for Prescription Drug Programs	20130303

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	V03AB	Antidotes	ATC1-4		methylene blue
ATC	A03BA	Belladonna alkaloids, tertiary amines	ATC1-4		hyoscyamine
ATC	J01XX	Other antibacterials	ATC1-4		methenamine
ATC	V04CG	Tests for gastric secretion	ATC1-4		methylene blue
MEDRT	D064692	Hyoscyamine	CHEM	has_ingredient	hyoscyamine sulfate
MEDRT	D064692	Hyoscyamine	CHEM	has_ingredient	hyoscyamine
MEDRT	D008709	Methenamine	CHEM	has_ingredient	methenamine
MEDRT	D008751	Methylene Blue	CHEM	has_ingredient	methylene blue
MEDRT	D010710	Phosphates	CHEM	has_ingredient	sodium phosphate, monobasic
MEDRT	D013449	Sulfonamides	CHEM	ci_chemclass	methenamine
MEDRT	D000014	Abnormalities, Drug-Induced	DISEASE	may_treat	hyoscyamine
MEDRT	D000014	Abnormalities, Drug-Induced	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D000471	Alkalosis	DISEASE	ci_with	sodium phosphate, monobasic
MEDRT	D001437	Bacteriuria	DISEASE	may_treat	methenamine
MEDRT	D003085	Colic	DISEASE	may_treat	hyoscyamine
MEDRT	D003085	Colic	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D003093	Colitis, Ulcerative	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D003093	Colitis, Ulcerative	DISEASE	ci_with	hyoscyamine
MEDRT	D003248	Constipation	DISEASE	may_treat	sodium phosphate, monobasic
MEDRT	D003490	Cyanosis	DISEASE	may_prevent	methylene blue
MEDRT	D003490	Cyanosis	DISEASE	may_treat	methylene blue
MEDRT	D003556	Cystitis	DISEASE	may_treat	methenamine
MEDRT	D003681	Dehydration	DISEASE	ci_with	methenamine
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	sodium phosphate, monobasic
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	hyoscyamine
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	methylene blue
MEDRT	D004487	Edema	DISEASE	ci_with	sodium phosphate, monobasic
MEDRT	D004927	Escherichia coli Infections	DISEASE	may_treat	methenamine
MEDRT	D018589	Gastroparesis	DISEASE	induces	hyoscyamine
MEDRT	D018589	Gastroparesis	DISEASE	induces	hyoscyamine sulfate
MEDRT	D005901	Glaucoma	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D005901	Glaucoma	DISEASE	ci_with	hyoscyamine
MEDRT	D048550	Hepatic Insufficiency	DISEASE	ci_with	methenamine
MEDRT	D006561	Herpes Simplex	DISEASE	may_treat	methylene blue
MEDRT	D006945	Hyperhidrosis	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D006945	Hyperhidrosis	DISEASE	may_treat	hyoscyamine
MEDRT	D006955	Hypernatremia	DISEASE	ci_with	sodium phosphate, monobasic
MEDRT	D006967	Hypersensitivity	DISEASE	ci_with	methenamine
MEDRT	D006996	Hypocalcemia	DISEASE	ci_with	sodium phosphate, monobasic
MEDRT	D017674	Hypophosphatemia	DISEASE	may_prevent	sodium phosphate, monobasic
MEDRT	D017674	Hypophosphatemia	DISEASE	may_treat	sodium phosphate, monobasic
MEDRT	D007077	Ileal Diseases	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D007077	Ileal Diseases	DISEASE	ci_with	hyoscyamine
MEDRT	D007415	Intestinal Obstruction	DISEASE	ci_with	hyoscyamine
MEDRT	D007415	Intestinal Obstruction	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D007431	Intraoperative Complications	DISEASE	may_treat	hyoscyamine
MEDRT	D007431	Intraoperative Complications	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D043183	Irritable Bowel Syndrome	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D043183	Irritable Bowel Syndrome	DISEASE	may_treat	hyoscyamine
MEDRT	D007674	Kidney Diseases	DISEASE	ci_with	methenamine
MEDRT	D020347	Lithiasis	DISEASE	may_treat	methylene blue
MEDRT	D008532	Megacolon, Toxic	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D008532	Megacolon, Toxic	DISEASE	ci_with	hyoscyamine
MEDRT	D008708	Methemoglobinemia	DISEASE	induces	methylene blue
MEDRT	D008708	Methemoglobinemia	DISEASE	may_treat	methylene blue
MEDRT	D009127	Muscle Rigidity	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D009127	Muscle Rigidity	DISEASE	may_treat	hyoscyamine
MEDRT	D009157	Myasthenia Gravis	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D009157	Myasthenia Gravis	DISEASE	ci_with	hyoscyamine
MEDRT	D017202	Myocardial Ischemia	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D017202	Myocardial Ischemia	DISEASE	ci_with	hyoscyamine
MEDRT	D010437	Peptic Ulcer	DISEASE	may_treat	hyoscyamine
MEDRT	D010437	Peptic Ulcer	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D011041	Poisoning	DISEASE	may_treat	methylene blue
MEDRT	D011247	Pregnancy	DISEASE	ci_with	methylene blue
MEDRT	D011654	Pulmonary Edema	DISEASE	ci_with	sodium phosphate, monobasic
MEDRT	D051437	Renal Insufficiency	DISEASE	ci_with	sodium phosphate, monobasic
MEDRT	D051437	Renal Insufficiency	DISEASE	ci_with	methylene blue
MEDRT	D012220	Rhinitis	DISEASE	may_treat	hyoscyamine
MEDRT	D012220	Rhinitis	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D012771	Shock, Hemorrhagic	DISEASE	ci_with	hyoscyamine
MEDRT	D012771	Shock, Hemorrhagic	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D012798	Sialorrhea	DISEASE	may_treat	hyoscyamine
MEDRT	D012798	Sialorrhea	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D013035	Spasm	DISEASE	may_treat	hyoscyamine
MEDRT	D013035	Spasm	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D013203	Staphylococcal Infections	DISEASE	may_treat	methenamine
MEDRT	D014202	Tremor	DISEASE	may_treat	hyoscyamine
MEDRT	D014202	Tremor	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D014524	Urethral Obstruction	DISEASE	ci_with	hyoscyamine
MEDRT	D014524	Urethral Obstruction	DISEASE	ci_with	hyoscyamine sulfate
MEDRT	D001750	Urinary Bladder, Neurogenic	DISEASE	may_treat	hyoscyamine
MEDRT	D001750	Urinary Bladder, Neurogenic	DISEASE	may_treat	hyoscyamine sulfate
MEDRT	D014552	Urinary Tract Infections	DISEASE	may_prevent	methenamine
MEDRT	D014552	Urinary Tract Infections	DISEASE	may_treat	methylene blue
MEDRT	D020924	Urological Manifestations	DISEASE	may_treat	sodium phosphate, monobasic
MEDRT	D014987	Xerostomia	DISEASE	induces	hyoscyamine sulfate
MEDRT	D014987	Xerostomia	DISEASE	induces	hyoscyamine
MEDRT	N0000000236	Alkylating Activity	MOA	has_moa	methylene blue
MEDRT	N0000175355	Binding Activity	MOA	has_moa	methylene blue
MEDRT	N0000000125	Cholinergic Muscarinic Antagonists	MOA	has_moa	hyoscyamine
MEDRT	N0000000125	Cholinergic Muscarinic Antagonists	MOA	has_moa	hyoscyamine sulfate
MEDRT	N0000000220	Electrolyte Activity	MOA	has_moa	sodium phosphate, monobasic
MEDRT	N0000000207	Histamine Receptor Antagonists	MOA	has_moa	hyoscyamine
MEDRT	N0000000207	Histamine Receptor Antagonists	MOA	has_moa	hyoscyamine sulfate
MEDRT	N0000010288	Osmotic Activity	MOA	has_moa	sodium phosphate, monobasic
MEDRT	N0000000130	Serotonin Antagonists	MOA	has_moa	hyoscyamine
MEDRT	N0000000130	Serotonin Antagonists	MOA	has_moa	hyoscyamine sulfate
MEDRT	N0000008331	Cardiovascular Activity Alteration	PE	has_pe	hyoscyamine
MEDRT	N0000008331	Cardiovascular Activity Alteration	PE	has_pe	hyoscyamine sulfate
MEDRT	N0000008337	Cellular Activity Alteration	PE	has_pe	sodium phosphate, monobasic
MEDRT	N0000008337	Cellular Activity Alteration	PE	has_pe	methenamine
MEDRT	N0000008337	Cellular Activity Alteration	PE	has_pe	methylene blue
MEDRT	N0000008868	Decreased Respiratory Secretions	PE	has_pe	hyoscyamine
MEDRT	N0000008868	Decreased Respiratory Secretions	PE	has_pe	hyoscyamine sulfate
MEDRT	N0000009371	Increased Large Intestinal Motility	PE	has_pe	sodium phosphate, monobasic
MEDRT	N0000009399	Increased Metabolic Rate	PE	has_pe	methylene blue
MEDRT	N0000009782	Oxygen Carrying Capacity Alteration	PE	has_pe	methylene blue
MEDRT	N0000009845	Small Intestine Fluid/Electrolyte Absorption Alteration	PE	has_pe	sodium phosphate, monobasic

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Urogesic Blue Reformulated Apr 2012	rxnav_allrelated
DF	DF	Oral Tablet	rxnav_allrelated
DFG	DFG	Oral Product	rxnav_allrelated
DFG	DFG	Pill	rxnav_allrelated
IN	IN	hyoscyamine	rxnav_allrelated
IN	IN	methenamine	rxnav_allrelated
IN	IN	methylene blue	rxnav_allrelated
IN	IN	sodium phosphate, monobasic	rxnav_allrelated
MIN	MIN	hyoscyamine / methenamine / methylene blue / sodium phosphate, monobasic	rxnav_allrelated
PIN	PIN	hyoscyamine sulfate	rxnav_allrelated
SBD	SBD	hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Urogesic Blue Reformulated Apr 2012]	rxnav_allrelated
SBDC	SBDC	hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG [Urogesic Blue Reformulated Apr 2012]	rxnav_allrelated
SBDF	SBDF	hyoscyamine / methenamine / methylene blue / sodium phosphate, monobasic Oral Tablet [Urogesic Blue Reformulated Apr 2012]	rxnav_allrelated
SBDFP	SBDFP	hyoscyamine sulfate / methenamine / methylene blue / sodium phosphate, monobasic Oral Tablet [Urogesic Blue Reformulated Apr 2012]	rxnav_allrelated
SBDG	SBDG	Urogesic Blue Reformulated Apr 2012 Oral Product	rxnav_allrelated
SBDG	SBDG	Urogesic Blue Reformulated Apr 2012 Pill	rxnav_allrelated
SCD	SCD	hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet	rxnav_allrelated
SCDC	SCDC	hyoscyamine sulfate 0.12 MG	rxnav_allrelated
SCDC	SCDC	methenamine 81.6 MG	rxnav_allrelated
SCDC	SCDC	methylene blue 10.8 MG	rxnav_allrelated
SCDC	SCDC	sodium phosphate, monobasic 40.8 MG	rxnav_allrelated
SCDF	SCDF	hyoscyamine / methenamine / methylene blue / sodium phosphate, monobasic Oral Tablet	rxnav_allrelated
SCDFP	SCDFP	hyoscyamine sulfate / methenamine / methylene blue / sodium phosphate, monobasic Oral Tablet	rxnav_allrelated
SCDG	SCDG	hyoscyamine / methenamine / methylene blue / sodium phosphate, monobasic Oral Product	rxnav_allrelated
SCDG	SCDG	hyoscyamine / methenamine / methylene blue / sodium phosphate, monobasic Pill	rxnav_allrelated
SCDGP	SCDGP	hyoscyamine sulfate / methenamine / methylene blue / sodium phosphate, monobasic Oral Product	rxnav_allrelated
SCDGP	SCDGP	hyoscyamine sulfate / methenamine / methylene blue / sodium phosphate, monobasic Pill	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	0.12 MG / 81.6 MG / 10.8 MG / 40.8 MG
ATTRIBUTES	GENERAL_CARDINALITY	MULTI
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	SCHEDULE	0
CODES	VUID	4010333
NAMES	Prescribable Synonym	UROGESIC-BLUE 81.6 MG / 40.8 MG / 10.8 MG / 0.12 MG Oral Tablet, Reformulated Apr 2012
SOURCES	Source	Gold Standard Alchemy
SOURCES	Source	Metathesaurus FDA Structured Product Labels
SOURCES	Source	Micromedex RED BOOK
SOURCES	Source	Multum MediSource Lexicon
SOURCES	Source	Veterans Health Administration National Drug File